Kevin P. Danahy resigned from his position as Chief Commercial Officer of Pulse Biosciences, Inc. on February 27, 2026. His resignation was effective immediately. The company stated that Mr. Danahy's departure was not due to any disagreement regarding operations, policies, practices, or accounting issues. Management acknowledged Mr. Danahy's important role in senior management and early commercialization efforts.